Interest Groups

Mylan may have violated antitrust law in its EpiPen sales to schools - Health Care and Life Sciences News

Get the news you want the way you want it: click the RSS button in the right corner to add this feed to your RSS reader, or click here to subscribe to this content. By subscribing, you’ll find this news on your Member Account page, and the latest articles will be emailed to you in your customized IndyBar E-Bulletin e-newsletter.

Health Care and Life Sciences News


Posted on: Aug 26, 2016

For years, Mylan Pharmaceuticals has been selling the devices to schools at a discounted price, giving them a break from rising costs. But the program also prohibited schools from buying competitors’ devices — a provision that experts say may have violated antitrust law.

Continue reading the article here.

If you would like to submit content or write an article for the Health Care & Life Sciences page, please email Kim Ferguson at kferguson@indybar.org.

DID YOU KNOW?

Indianapolis Bar Association (IndyBar) est. 1878 | 4,536 Members (as of 2.11.21)